PENTRAXIN 3 AS GRAFT-VERSUS-HOST DISEASE (GVHD) BIOMARKER IN A COHORT OF PEDIATRIC PATIENTS WITH HEMATO-ONCOLOGIC DISEASES

被引：0

作者：

Dander, E. ^{[1
]}

De Lorenzo, P. ^{[1
,2
]}

Masciocchi, F. ^{[3
]}

Vinci, P. ^{[1
]}

Pasqualin, F. ^{[4
]}

Bonanomi, S. ^{[3
]}

Gregorio, Di ^{[1
]}

Migliavacca, M. ^{[3
]}

Pavan, F. ^{[3
]}

Di Maio, L. ^{[3
]}

Garlanda, C. ^{[4
]}

Mantovani, A. ^{[4
,5
]}

Biondi, A. ^{[1
]}

Valsecchi, M. G. ^{[2
]}

Balduzzi, A. ^{[3
]}

Bottazzi, B. ^{[4
]}

Rovelli, A. ^{[3
]}

D'Amico, G. ^{[1
]}

机构：

[1] Univ Milano Bicocca, Osped San Gerardo, Fdn MBBM, Ctr Ric Tettamanti,Clin Pediat, Monza, Italy

[2] Univ Milano Bicocca, Ctr Biostat Epidemiol Clin, Monza, Italy

[3] Univ Milano Bicocca, Osped San Gerardo, Fdn MBBM, Ctr Trapianti Midollo Osseo, Monza, Italy

[4] Univ Milan, Ist Clin Humanitas, Dipartimento Immunol & Infiammaz, Milan, Italy

[5] Univ Milan, Dipartimento Biotecnol & Med Traslaz, Milan, Italy

来源：

BONE MARROW TRANSPLANTATION | 2014年 / 49卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

PH-P441

引用

页码：S312 / S312

页数：1

共 50 条

[1] GRAFT-VERSUS-HOST DISEASE (GVHD)
VOLCPLATZER, B
HAUTARZT, 1992, 43 (10): : 669 - 677
[2] Pentraxin 3: a new potential biomarker for predicting and monitoring graft-versus-host disease (GvHD) in allogeneic hematopoietic stem cell transplantated (HSCT) patients
Dander, E.
Vinci, P.
De Lorenzo, P.
Cuccovillo, I.
Migliavacca, M.
Bonanomi, S.
Balduzzi, A.
Pavan, F.
Di Maio, L.
Masciocchi, F.
Teruzzi, E.
Garlanda, C.
Mantovani, A.
Rambaldi, A.
Valsecchi, M. G.
Rovelli, A.
Bottazzi, B.
Biondi, A.
D'Amico, G.
IMMUNOLOGY, 2012, 137 : 748 - 748
[3] Late relapse in patients with Graft-Versus-Host Disease (GVHD)
Ferrant, A
Straetmans, N
Latinne, D
Van den Neste, E
Michaux, L
BONE MARROW TRANSPLANTATION, 2001, 27 : S172 - S173
[4] PENTRAXIN-3 INCREASES AT THE ONSET OF GRAFT-VERSUS-HOST DISEASE IN TRANSPLANTED PATIENTS
Dander, E.
Vinci, P.
De Lorenzo, P.
Cuccovillo, I.
Bonanomi, S.
Balduzzi, A.
Migliavacca, M.
Di Maio, L.
Pavan, F.
Teruzzi, E.
Garlanda, C.
Mantovani, A.
Valsecchi, M.
Rovelli, A.
Bottazzi, B.
Biondi, A.
D'Amico, G.
HAEMATOLOGICA, 2012, 97 : 415 - 415
[5] Use of Ruxolitinib in Pediatric Patients with Steroid-Refractory Graft-versus-host Disease (GVHD)
Becilli, Marco
Merli, Pietro
Pagliara, Daria
Galaverna, Federica
Algeri, Mattia
Gaspari, Stefania
Boccieri, Emilia
Carta, Roberto
Ruggeri, Annalisa
Locatelli, Franco
BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 631 - 631
[6] GENETIC INFLUENCES ON GRAFT-VERSUS-HOST DISEASE (GVHD)
ALLEN, RD
FASEB JOURNAL, 1995, 9 (03): : A501 - A501
[7] Rosiglitazone prevents graft-versus-host disease (GVHD)
Song, Eun-Kee
Yim, Jun-Mo
Yim, Joo-Yun
Song, Min-Young
Rho, Hye-Won
Yim, Sung Kyun
Jeon, So Yeon
Kim, Hee Sun
Yhim, Ho-Young
Lee, Na-Ri
Kwak, Jae-Yong
Sohn, Myung-Hee
Park, Ho Sung
Jang, Kyu Yun
Yim, Chang-Yeol
TRANSPLANT IMMUNOLOGY, 2012, 27 (2-3) : 128 - 137
[8] Chronic Graft-Versus-Host Disease (GVHD) in Children
Baird, Kristin
Cooke, Kenneth
Schultz, Kirk R.
PEDIATRIC CLINICS OF NORTH AMERICA, 2010, 57 (01) : 297 - +
[9] Rosiglitazone prevents graft-versus-host disease (GVHD)
Song, Eun-Kee
Yhim, Ho-Young
Yim, Jun-Mo
Yim, Joo-Yun
Song, Min-Young
Lee, Na-Ri
Kwak, Jae-Yong
Yim, Chang-Yeol
Sohn, Myung-Hee
CANCER RESEARCH, 2012, 72
[10] OPHTHALMOLOGICAL FINDINGS IN GRAFT-VERSUS-HOST DISEASE (GVHD)
KASMANN, B
RUPRECHT, KW
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1993, 202 (06) : 491 - 499

← 1 2 3 4 5 →